MA NEWS why is Mastercard Incorporated price falling or rising
MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising
MA Mastercard Incorporated is falling or rising technical reasons
Technical analysis forecast of Mastercard Incorporated Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Mastercard Incorporated MA at this time. Stock is rising and might rise more.
It appears as if Mastercard Incorporated MA gave a large move recently.
Stock of Mastercard Incorporated (MA) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Mastercard Incorporated is bullish for shortterm, and stock might move up till 628.6 or till 660.7. Use a stoploss of 601.82 and if this stock hits its stoploss, then it can fall down till 575.04
MA Mastercard Incorporated is falling or rising NEWS fundamental reasons
Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat Mankind Pharma share price: Going ahead, improving domestic volumes, rising chronic contribution and sustained export momentum are expected to support growth, say analysts. - NEWS as on 2026-10-27 business-standard.com
Mankind Pharma Q2 PAT rises 37.7% on strong domestic chronic business The drugmaker's revenue rose 17.3 per cent to ?4,338 crore in Q2 FY27, supported by strong demand for chronic therapies and growth in Bharat Serums and Vaccines' speciality portfolio. - NEWS as on 2026-10-26 business-standard.com
IRSA Inversiones y Representaciones Sociedad Anónima Announces Shareholders' Meeting Resolutions Including ARS 211,000,000,000 Dividend and Merger Approval IRSA Inversiones y Representaciones Sociedad Anónima announced the resolutions from its Ordinary and Extraordinary General Shareholders' Meeting held on October 22, 2026. Shareholders approved the financial documentation for the fiscal year ended Ju - NEWS as on 2026-10-23 nasdaq.com
Sun Pharma accepts bids worth ?7,816 crore for two five-year bonds Sun Pharma has accepted bids worth ?7,816 crore for two bond tranches maturing in five years and one day, offering annual coupons of 8.05% and 8.20%, merchant bankers said. - NEWS as on 2026-10-22 business-standard.com
TVS ILP leases 80k sq ft at Visakhapatnam park in Andhra to Yokohoma group TVS ILP has leased 80,000 square feet in Visakhapatnam to ATC Tires for a new warehouse. This facility will support domestic distribution and export operations for Yokohama passenger car tires. The development is expected to create local employment opportu - NEWS as on 2026-10-21 indiatimes.com
Solara Active Pharma share price zooms 16% on Q2 turnaround; H1 net up 103x Solara Active Pharma Sciences reported a consolidated net profit of ?28.59 crore in Q2FY27 and ?44.70 crore in H1FY27. It posted a loss of ?9.29 crore in Q2FY26 and profit of ?0.42 crore in H1FY26. - NEWS as on 2026-10-16 business-standard.com
Mankind Pharma to acquire 70% in Belgian biotech firm for €48 million Deal marks entry into next-generation CAR-T cancer therapies as company expands global innovation ambitions - NEWS as on 2026-10-15 business-standard.com
Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leaders Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They highlight the importance of regulatory reforms and a strong ecosystem for research and development. Industry executives m - NEWS as on 2026-10-05 indiatimes.com
Kuku revenue jumps sixfold to ?1,484 crore as AI fuels microdrama expansion The Kuku TV and Kuku FM parent reported FY26 net revenue of ?1,484 crore and a profit of ?182 crore, as it builds a 1,000-member AI-led production unit ahead of its planned IPO - NEWS as on 2026-10-03 business-standard.com
Franco-Nevada Sees 45% Growth if Cobre Panama Restarts MarketBeat Week in Review – 08/10 - 08/14Franco-Nevada (NYSE:FNV) outlined its approach to profitable growth, citing a focus on return on capital, flexible financing structures and partnerships with operating teams, while highlighting potential produ - NEWS as on 2026-10-01 nasdaq.com
RIL Q2 Results: Nuvama sees 17% EBITDA growth, led by O2C biz. Here’s what to expect Reliance Industries is expected to report 17% year-on-year growth in Q2FY27 EBITDA to Rs 53,700 crore, led by stronger refining margins and higher throughput, according to Nuvama Research. While the O2C business is likely to drive near-term earnings, New E - NEWS as on 2026-10-01 indiatimes.com
More announcements and NEWS
MA Mastercard Incorporated current price & indicator signals
Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 27 Tue Oct 2026 | 609.95 | 605.81 to 614.48 | -0.58% | 0.67 times |
| 26 Mon Oct 2026 | 613.50 | 611.37 to 622.76 | -1.62% | 0.9 times |
| 23 Fri Oct 2026 | 623.60 | 619.59 to 631.12 | -1.44% | 0.87 times |
| 22 Thu Oct 2026 | 632.74 | 621.01 to 633.29 | 1.63% | 0.67 times |
| 21 Wed Oct 2026 | 622.62 | 617.37 to 624.66 | 0.35% | 0.89 times |
| 20 Tue Oct 2026 | 620.42 | 616.59 to 624.29 | 0.65% | 0.97 times |
| 19 Mon Oct 2026 | 616.40 | 608.59 to 618.00 | -0.17% | 0.96 times |
| 16 Fri Oct 2026 | 617.42 | 613.32 to 622.49 | 0.18% | 1.11 times |
| 15 Thu Oct 2026 | 616.32 | 607.06 to 619.80 | 2.17% | 1.37 times |
| 14 Wed Oct 2026 | 603.24 | 600.65 to 606.61 | -0.26% | 1.05 times |
| 13 Tue Oct 2026 | 604.80 | 597.13 to 605.60 | 1.63% | 1.2 times |
| 12 Mon Oct 2026 | 595.09 | 590.21 to 598.95 | 1.01% | 0.94 times |
Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


